Henry O - Search Results

1

Hemagglutinin and neuraminidase containing virus-like particles produced in HEK-293 suspension culture: An effective influenza vaccine candidate.

Venereo-Sanchez A, Gilbert R, Simoneau M, Caron A, Chahal P, Chen W, Ansorge S, Li X, Henry O, Kamen A. Venereo-Sanchez A, et al. Among authors: henry o. Vaccine. 2016 Jun 17;34(29):3371-80. doi: 10.1016/j.vaccine.2016.04.089. Epub 2016 May 5. Vaccine. 2016. PMID: 27155499

2

Development and optimization of an adenovirus production process.

Kamen A, Henry O. Kamen A, et al. Among authors: henry o. J Gene Med. 2004 Feb;6 Suppl 1:S184-92. doi: 10.1002/jgm.503. J Gene Med. 2004. PMID: 14978761 Review.

3

Insights into adenoviral vector production kinetics in acoustic filter-based perfusion cultures.

Henry O, Dormond E, Perrier M, Kamen A. Henry O, et al. Biotechnol Bioeng. 2004 Jun 30;86(7):765-74. doi: 10.1002/bit.20074. Biotechnol Bioeng. 2004. PMID: 15162452

4

Metabolic flux analysis of HEK-293 cells in perfusion cultures for the production of adenoviral vectors.

Henry O, Perrier M, Kamen A. Henry O, et al. Metab Eng. 2005 Sep-Nov;7(5-6):467-76. doi: 10.1016/j.ymben.2005.08.002. Epub 2005 Sep 28. Metab Eng. 2005. PMID: 16198135

5

Development of a scalable process for high-yield lentiviral vector production by transient transfection of HEK293 suspension cultures.

Ansorge S, Lanthier S, Transfiguracion J, Durocher Y, Henry O, Kamen A. Ansorge S, et al. Among authors: henry o. J Gene Med. 2009 Oct;11(10):868-76. doi: 10.1002/jgm.1370. J Gene Med. 2009. PMID: 19618482

6

Scalable production of influenza virus in HEK-293 cells for efficient vaccine manufacturing.

Le Ru A, Jacob D, Transfiguracion J, Ansorge S, Henry O, Kamen AA. Le Ru A, et al. Among authors: henry o. Vaccine. 2010 May 7;28(21):3661-71. doi: 10.1016/j.vaccine.2010.03.029. Epub 2010 Mar 26. Vaccine. 2010. PMID: 20347632

7

Unraveling the metabolism of HEK-293 cells using lactate isotopomer analysis.

Henry O, Jolicoeur M, Kamen A. Henry O, et al. Bioprocess Biosyst Eng. 2011 Mar;34(3):263-73. doi: 10.1007/s00449-010-0468-9. Epub 2010 Sep 17. Bioprocess Biosyst Eng. 2011. PMID: 20848294

8

Analytical technologies for influenza virus-like particle candidate vaccines: challenges and emerging approaches.

Thompson CM, Petiot E, Lennaertz A, Henry O, Kamen AA. Thompson CM, et al. Among authors: henry o. Virol J. 2013 May 4;10:141. doi: 10.1186/1743-422X-10-141. Virol J. 2013. PMID: 23642219 Free PMC article. Review.

9

Critical assessment of influenza VLP production in Sf9 and HEK293 expression systems.

Thompson CM, Petiot E, Mullick A, Aucoin MG, Henry O, Kamen AA. Thompson CM, et al. Among authors: henry o. BMC Biotechnol. 2015 May 16;15:31. doi: 10.1186/s12896-015-0152-x. BMC Biotechnol. 2015. PMID: 25981500 Free PMC article.

10

Process intensification for high yield production of influenza H1N1 Gag virus-like particles using an inducible HEK-293 stable cell line.

Venereo-Sanchez A, Simoneau M, Lanthier S, Chahal P, Bourget L, Ansorge S, Gilbert R, Henry O, Kamen A. Venereo-Sanchez A, et al. Among authors: henry o. Vaccine. 2017 Jul 24;35(33):4220-4228. doi: 10.1016/j.vaccine.2017.06.024. Epub 2017 Jun 22. Vaccine. 2017. PMID: 28648546

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

251 results

Search Page

Filters